Global Opioid Antagonist Supply, Demand and Key Producers, 2024-2030
Page: 120
Published Date: 19 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Opioid Antagonist market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report studies the global Opioid Antagonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioid Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioid Antagonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioid Antagonist total production and demand, 2019-2030, (K Units)
Global Opioid Antagonist total production value, 2019-2030, (USD Million)
Global Opioid Antagonist production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Opioid Antagonist consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Opioid Antagonist domestic production, consumption, key domestic manufacturers and share
Global Opioid Antagonist production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Opioid Antagonist production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Opioid Antagonist production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Opioid Antagonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Indivior, Alkermes, Titan Pharmaceuticals, Opiant Pharmaceuticals, Hikma Pharmaceuticals, Orexo, Camurus, Acura Pharmaceuticals and Shionogi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioid Antagonist market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Opioid Antagonist Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Opioid Antagonist Market, Segmentation by Type
Oral
Parenteral
Global Opioid Antagonist Market, Segmentation by Application
Hospitals
Clinics
Others
Companies Profiled:
Indivior
Alkermes
Titan Pharmaceuticals
Opiant Pharmaceuticals
Hikma Pharmaceuticals
Orexo
Camurus
Acura Pharmaceuticals
Shionogi
BioDelivery Sciences International
Collegium Pharmaceutical
AstraZeneca
Key Questions Answered
1. How big is the global Opioid Antagonist market?
2. What is the demand of the global Opioid Antagonist market?
3. What is the year over year growth of the global Opioid Antagonist market?
4. What is the production and production value of the global Opioid Antagonist market?
5. Who are the key producers in the global Opioid Antagonist market?
Table of Contents
1 Supply Summary
1.1 Opioid Antagonist Introduction
1.2 World Opioid Antagonist Supply & Forecast
1.2.1 World Opioid Antagonist Production Value (2019 & 2023 & 2030)
1.2.2 World Opioid Antagonist Production (2019-2030)
1.2.3 World Opioid Antagonist Pricing Trends (2019-2030)
1.3 World Opioid Antagonist Production by Region (Based on Production Site)
1.3.1 World Opioid Antagonist Production Value by Region (2019-2030)
1.3.2 World Opioid Antagonist Production by Region (2019-2030)
1.3.3 World Opioid Antagonist Average Price by Region (2019-2030)
1.3.4 North America Opioid Antagonist Production (2019-2030)
1.3.5 Europe Opioid Antagonist Production (2019-2030)
1.3.6 China Opioid Antagonist Production (2019-2030)
1.3.7 Japan Opioid Antagonist Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Opioid Antagonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Opioid Antagonist Major Market Trends
2.1 World Opioid Antagonist Demand (2019-2030)
2.2 World Opioid Antagonist Consumption by Region
2.2.1 World Opioid Antagonist Consumption by Region (2019-2024)
2.2.2 World Opioid Antagonist Consumption Forecast by Region (2025-2030)
2.3 United States Opioid Antagonist Consumption (2019-2030)
2.4 China Opioid Antagonist Consumption (2019-2030)
2.5 Europe Opioid Antagonist Consumption (2019-2030)
2.6 Japan Opioid Antagonist Consumption (2019-2030)
2.7 South Korea Opioid Antagonist Consumption (2019-2030)
2.8 ASEAN Opioid Antagonist Consumption (2019-2030)
2.9 India Opioid Antagonist Consumption (2019-2030)
3.1 World Opioid Antagonist Production Value by Manufacturer (2019-2024)
3.2 World Opioid Antagonist Production by Manufacturer (2019-2024)
3.3 World Opioid Antagonist Average Price by Manufacturer (2019-2024)
3.4 Opioid Antagonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Opioid Antagonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Opioid Antagonist in 2023
3.5.3 Global Concentration Ratios (CR8) for Opioid Antagonist in 2023
3.6 Opioid Antagonist Market: Overall Company Footprint Analysis
3.6.1 Opioid Antagonist Market: Region Footprint
3.6.2 Opioid Antagonist Market: Company Product Type Footprint
3.6.3 Opioid Antagonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Opioid Antagonist Production Value Comparison
4.1.1 United States VS China: Opioid Antagonist Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Opioid Antagonist Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Opioid Antagonist Production Comparison
4.2.1 United States VS China: Opioid Antagonist Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Opioid Antagonist Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Opioid Antagonist Consumption Comparison
4.3.1 United States VS China: Opioid Antagonist Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Opioid Antagonist Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Opioid Antagonist Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Opioid Antagonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Opioid Antagonist Production Value (2019-2024)
4.4.3 United States Based Manufacturers Opioid Antagonist Production (2019-2024)
4.5 China Based Opioid Antagonist Manufacturers and Market Share
4.5.1 China Based Opioid Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Opioid Antagonist Production Value (2019-2024)
4.5.3 China Based Manufacturers Opioid Antagonist Production (2019-2024)
4.6 Rest of World Based Opioid Antagonist Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Opioid Antagonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Opioid Antagonist Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Opioid Antagonist Production (2019-2024)
5.1 World Opioid Antagonist Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Parenteral
5.3 Market Segment by Type
5.3.1 World Opioid Antagonist Production by Type (2019-2030)
5.3.2 World Opioid Antagonist Production Value by Type (2019-2030)
5.3.3 World Opioid Antagonist Average Price by Type (2019-2030)
6.1 World Opioid Antagonist Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Opioid Antagonist Production by Application (2019-2030)
6.3.2 World Opioid Antagonist Production Value by Application (2019-2030)
6.3.3 World Opioid Antagonist Average Price by Application (2019-2030)
7.1 Indivior
7.1.1 Indivior Details
7.1.2 Indivior Major Business
7.1.3 Indivior Opioid Antagonist Product and Services
7.1.4 Indivior Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Indivior Recent Developments/Updates
7.1.6 Indivior Competitive Strengths & Weaknesses
7.2 Alkermes
7.2.1 Alkermes Details
7.2.2 Alkermes Major Business
7.2.3 Alkermes Opioid Antagonist Product and Services
7.2.4 Alkermes Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Alkermes Recent Developments/Updates
7.2.6 Alkermes Competitive Strengths & Weaknesses
7.3 Titan Pharmaceuticals
7.3.1 Titan Pharmaceuticals Details
7.3.2 Titan Pharmaceuticals Major Business
7.3.3 Titan Pharmaceuticals Opioid Antagonist Product and Services
7.3.4 Titan Pharmaceuticals Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Titan Pharmaceuticals Recent Developments/Updates
7.3.6 Titan Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Opiant Pharmaceuticals
7.4.1 Opiant Pharmaceuticals Details
7.4.2 Opiant Pharmaceuticals Major Business
7.4.3 Opiant Pharmaceuticals Opioid Antagonist Product and Services
7.4.4 Opiant Pharmaceuticals Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Opiant Pharmaceuticals Recent Developments/Updates
7.4.6 Opiant Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Hikma Pharmaceuticals
7.5.1 Hikma Pharmaceuticals Details
7.5.2 Hikma Pharmaceuticals Major Business
7.5.3 Hikma Pharmaceuticals Opioid Antagonist Product and Services
7.5.4 Hikma Pharmaceuticals Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Hikma Pharmaceuticals Recent Developments/Updates
7.5.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Orexo
7.6.1 Orexo Details
7.6.2 Orexo Major Business
7.6.3 Orexo Opioid Antagonist Product and Services
7.6.4 Orexo Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Orexo Recent Developments/Updates
7.6.6 Orexo Competitive Strengths & Weaknesses
7.7 Camurus
7.7.1 Camurus Details
7.7.2 Camurus Major Business
7.7.3 Camurus Opioid Antagonist Product and Services
7.7.4 Camurus Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Camurus Recent Developments/Updates
7.7.6 Camurus Competitive Strengths & Weaknesses
7.8 Acura Pharmaceuticals
7.8.1 Acura Pharmaceuticals Details
7.8.2 Acura Pharmaceuticals Major Business
7.8.3 Acura Pharmaceuticals Opioid Antagonist Product and Services
7.8.4 Acura Pharmaceuticals Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Acura Pharmaceuticals Recent Developments/Updates
7.8.6 Acura Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Shionogi
7.9.1 Shionogi Details
7.9.2 Shionogi Major Business
7.9.3 Shionogi Opioid Antagonist Product and Services
7.9.4 Shionogi Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Shionogi Recent Developments/Updates
7.9.6 Shionogi Competitive Strengths & Weaknesses
7.10 BioDelivery Sciences International
7.10.1 BioDelivery Sciences International Details
7.10.2 BioDelivery Sciences International Major Business
7.10.3 BioDelivery Sciences International Opioid Antagonist Product and Services
7.10.4 BioDelivery Sciences International Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 BioDelivery Sciences International Recent Developments/Updates
7.10.6 BioDelivery Sciences International Competitive Strengths & Weaknesses
7.11 Collegium Pharmaceutical
7.11.1 Collegium Pharmaceutical Details
7.11.2 Collegium Pharmaceutical Major Business
7.11.3 Collegium Pharmaceutical Opioid Antagonist Product and Services
7.11.4 Collegium Pharmaceutical Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Collegium Pharmaceutical Recent Developments/Updates
7.11.6 Collegium Pharmaceutical Competitive Strengths & Weaknesses
7.12 AstraZeneca
7.12.1 AstraZeneca Details
7.12.2 AstraZeneca Major Business
7.12.3 AstraZeneca Opioid Antagonist Product and Services
7.12.4 AstraZeneca Opioid Antagonist Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 AstraZeneca Recent Developments/Updates
7.12.6 AstraZeneca Competitive Strengths & Weaknesses
8.1 Opioid Antagonist Industry Chain
8.2 Opioid Antagonist Upstream Analysis
8.2.1 Opioid Antagonist Core Raw Materials
8.2.2 Main Manufacturers of Opioid Antagonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Opioid Antagonist Production Mode
8.6 Opioid Antagonist Procurement Model
8.7 Opioid Antagonist Industry Sales Model and Sales Channels
8.7.1 Opioid Antagonist Sales Model
8.7.2 Opioid Antagonist Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Opioid Antagonist Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Opioid Antagonist Production Value by Region (2019-2024) & (USD Million)
Table 3. World Opioid Antagonist Production Value by Region (2025-2030) & (USD Million)
Table 4. World Opioid Antagonist Production Value Market Share by Region (2019-2024)
Table 5. World Opioid Antagonist Production Value Market Share by Region (2025-2030)
Table 6. World Opioid Antagonist Production by Region (2019-2024) & (K Units)
Table 7. World Opioid Antagonist Production by Region (2025-2030) & (K Units)
Table 8. World Opioid Antagonist Production Market Share by Region (2019-2024)
Table 9. World Opioid Antagonist Production Market Share by Region (2025-2030)
Table 10. World Opioid Antagonist Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Opioid Antagonist Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Opioid Antagonist Major Market Trends
Table 13. World Opioid Antagonist Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Opioid Antagonist Consumption by Region (2019-2024) & (K Units)
Table 15. World Opioid Antagonist Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Opioid Antagonist Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Opioid Antagonist Producers in 2023
Table 18. World Opioid Antagonist Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Opioid Antagonist Producers in 2023
Table 20. World Opioid Antagonist Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Opioid Antagonist Company Evaluation Quadrant
Table 22. World Opioid Antagonist Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Opioid Antagonist Production Site of Key Manufacturer
Table 24. Opioid Antagonist Market: Company Product Type Footprint
Table 25. Opioid Antagonist Market: Company Product Application Footprint
Table 26. Opioid Antagonist Competitive Factors
Table 27. Opioid Antagonist New Entrant and Capacity Expansion Plans
Table 28. Opioid Antagonist Mergers & Acquisitions Activity
Table 29. United States VS China Opioid Antagonist Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Opioid Antagonist Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Opioid Antagonist Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Opioid Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioid Antagonist Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Opioid Antagonist Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Opioid Antagonist Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Opioid Antagonist Production Market Share (2019-2024)
Table 37. China Based Opioid Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioid Antagonist Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Opioid Antagonist Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Opioid Antagonist Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Opioid Antagonist Production Market Share (2019-2024)
Table 42. Rest of World Based Opioid Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Opioid Antagonist Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioid Antagonist Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Opioid Antagonist Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Opioid Antagonist Production Market Share (2019-2024)
Table 47. World Opioid Antagonist Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Opioid Antagonist Production by Type (2019-2024) & (K Units)
Table 49. World Opioid Antagonist Production by Type (2025-2030) & (K Units)
Table 50. World Opioid Antagonist Production Value by Type (2019-2024) & (USD Million)
Table 51. World Opioid Antagonist Production Value by Type (2025-2030) & (USD Million)
Table 52. World Opioid Antagonist Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Opioid Antagonist Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Opioid Antagonist Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Opioid Antagonist Production by Application (2019-2024) & (K Units)
Table 56. World Opioid Antagonist Production by Application (2025-2030) & (K Units)
Table 57. World Opioid Antagonist Production Value by Application (2019-2024) & (USD Million)
Table 58. World Opioid Antagonist Production Value by Application (2025-2030) & (USD Million)
Table 59. World Opioid Antagonist Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Opioid Antagonist Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Indivior Basic Information, Manufacturing Base and Competitors
Table 62. Indivior Major Business
Table 63. Indivior Opioid Antagonist Product and Services
Table 64. Indivior Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Indivior Recent Developments/Updates
Table 66. Indivior Competitive Strengths & Weaknesses
Table 67. Alkermes Basic Information, Manufacturing Base and Competitors
Table 68. Alkermes Major Business
Table 69. Alkermes Opioid Antagonist Product and Services
Table 70. Alkermes Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Alkermes Recent Developments/Updates
Table 72. Alkermes Competitive Strengths & Weaknesses
Table 73. Titan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Titan Pharmaceuticals Major Business
Table 75. Titan Pharmaceuticals Opioid Antagonist Product and Services
Table 76. Titan Pharmaceuticals Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Titan Pharmaceuticals Recent Developments/Updates
Table 78. Titan Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Opiant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Opiant Pharmaceuticals Major Business
Table 81. Opiant Pharmaceuticals Opioid Antagonist Product and Services
Table 82. Opiant Pharmaceuticals Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Opiant Pharmaceuticals Recent Developments/Updates
Table 84. Opiant Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Hikma Pharmaceuticals Major Business
Table 87. Hikma Pharmaceuticals Opioid Antagonist Product and Services
Table 88. Hikma Pharmaceuticals Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Hikma Pharmaceuticals Recent Developments/Updates
Table 90. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Orexo Basic Information, Manufacturing Base and Competitors
Table 92. Orexo Major Business
Table 93. Orexo Opioid Antagonist Product and Services
Table 94. Orexo Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Orexo Recent Developments/Updates
Table 96. Orexo Competitive Strengths & Weaknesses
Table 97. Camurus Basic Information, Manufacturing Base and Competitors
Table 98. Camurus Major Business
Table 99. Camurus Opioid Antagonist Product and Services
Table 100. Camurus Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Camurus Recent Developments/Updates
Table 102. Camurus Competitive Strengths & Weaknesses
Table 103. Acura Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Acura Pharmaceuticals Major Business
Table 105. Acura Pharmaceuticals Opioid Antagonist Product and Services
Table 106. Acura Pharmaceuticals Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Acura Pharmaceuticals Recent Developments/Updates
Table 108. Acura Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Shionogi Basic Information, Manufacturing Base and Competitors
Table 110. Shionogi Major Business
Table 111. Shionogi Opioid Antagonist Product and Services
Table 112. Shionogi Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Shionogi Recent Developments/Updates
Table 114. Shionogi Competitive Strengths & Weaknesses
Table 115. BioDelivery Sciences International Basic Information, Manufacturing Base and Competitors
Table 116. BioDelivery Sciences International Major Business
Table 117. BioDelivery Sciences International Opioid Antagonist Product and Services
Table 118. BioDelivery Sciences International Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. BioDelivery Sciences International Recent Developments/Updates
Table 120. BioDelivery Sciences International Competitive Strengths & Weaknesses
Table 121. Collegium Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Collegium Pharmaceutical Major Business
Table 123. Collegium Pharmaceutical Opioid Antagonist Product and Services
Table 124. Collegium Pharmaceutical Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Collegium Pharmaceutical Recent Developments/Updates
Table 126. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 127. AstraZeneca Major Business
Table 128. AstraZeneca Opioid Antagonist Product and Services
Table 129. AstraZeneca Opioid Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 130. Global Key Players of Opioid Antagonist Upstream (Raw Materials)
Table 131. Opioid Antagonist Typical Customers
Table 132. Opioid Antagonist Typical Distributors
List of Figure
Figure 1. Opioid Antagonist Picture
Figure 2. World Opioid Antagonist Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Opioid Antagonist Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Opioid Antagonist Production (2019-2030) & (K Units)
Figure 5. World Opioid Antagonist Average Price (2019-2030) & (US$/Unit)
Figure 6. World Opioid Antagonist Production Value Market Share by Region (2019-2030)
Figure 7. World Opioid Antagonist Production Market Share by Region (2019-2030)
Figure 8. North America Opioid Antagonist Production (2019-2030) & (K Units)
Figure 9. Europe Opioid Antagonist Production (2019-2030) & (K Units)
Figure 10. China Opioid Antagonist Production (2019-2030) & (K Units)
Figure 11. Japan Opioid Antagonist Production (2019-2030) & (K Units)
Figure 12. Opioid Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 15. World Opioid Antagonist Consumption Market Share by Region (2019-2030)
Figure 16. United States Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 17. China Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 18. Europe Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 19. Japan Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 20. South Korea Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 22. India Opioid Antagonist Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Opioid Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Opioid Antagonist Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Opioid Antagonist Markets in 2023
Figure 26. United States VS China: Opioid Antagonist Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Opioid Antagonist Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Opioid Antagonist Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Opioid Antagonist Production Market Share 2023
Figure 30. China Based Manufacturers Opioid Antagonist Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Opioid Antagonist Production Market Share 2023
Figure 32. World Opioid Antagonist Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Opioid Antagonist Production Value Market Share by Type in 2023
Figure 34. Oral
Figure 35. Parenteral
Figure 36. World Opioid Antagonist Production Market Share by Type (2019-2030)
Figure 37. World Opioid Antagonist Production Value Market Share by Type (2019-2030)
Figure 38. World Opioid Antagonist Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Opioid Antagonist Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Opioid Antagonist Production Value Market Share by Application in 2023
Figure 41. Hospitals
Figure 42. Clinics
Figure 43. Others
Figure 44. World Opioid Antagonist Production Market Share by Application (2019-2030)
Figure 45. World Opioid Antagonist Production Value Market Share by Application (2019-2030)
Figure 46. World Opioid Antagonist Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Opioid Antagonist Industry Chain
Figure 48. Opioid Antagonist Procurement Model
Figure 49. Opioid Antagonist Sales Model
Figure 50. Opioid Antagonist Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Indivior Alkermes Titan Pharmaceuticals Opiant Pharmaceuticals Hikma Pharmaceuticals Orexo Camurus Acura Pharmaceuticals Shionogi BioDelivery Sciences International Collegium Pharmaceutical AstraZeneca
Related Reports
08 Sep 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
